← Open Payments lookup

KATHERINE CHIN: Open Payments

NPI 1063863785 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,574 in 88 payments from 23 companies in 2025. Trend: 2023 $526 · 2024 $805 · 2025 $2,574

Food & beverage: $2,459Education: $115
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.14$333
Janssen Biotech, Inc.6$307
Madrigal Pharmaceuticals9$282
Ardelyx, Inc.16$235
Abbott Laboratories2$211
Janssen Scientific Affairs, LLC2$188
Gilead Sciences, Inc.4$185
ABBVIE INC.7$133
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$116
GENZYME CORPORATION1$107

Products named: TREMFYA, REZDIFFRA, IBSRELA, DRAGONFLY OPSTAR, EOHILIA, ENTYVIO, DUPIXENT, Livdelzi.

Industry payments across CA — which companies pay providers there.